China: 35 Million Shots of Problematic Biokangtai Vaccines Sold
NTDTV·Published on Dec 24, 2013
35 million shots of problematic Biokangtai vaccines sold at Chinese market.
Full Story:
A total of 35 million shots of valid hepatitis B vaccine made by Biokangtai, suspected of causing the death of several newborns, have been sold across China.
It remains unclear where the 186 batches of problematic vaccines were dispatched and used in the country.
Four infants have died in south China's Guangdong Province, after inoculation with hepatitis B vaccines made by Biokangtai, a Shenzhen drug manufacturer.
Two babies in neighboring Hunan province and another in the southwest province of Sichuan, died of similar symptoms.
A ban on the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based company was issued.
So far Biokangtai refused to be interviewed on the issue.
Biokangtai is a major supplier of free hepatitis B vaccine, accounting for about 60 percent of the market share.
The Guangdong Disease Control and Prevention Center has procured 1.45 million shots of hepatitis B vaccine from other suppliers, which can meet demand for two or three months.
For more news and videos visit ☛
http://ntd.tv
Follow us on Twitter ☛
http://twitter.com/NTDTelevision
Add us on Facebook ☛
http://on.fb.me/s5KV2C